ZLAB:NASDAQ, Zai Lab Limited

ZLAB stock overview

Zai Lab Limited (ZLAB:NASDAQ) closed at $22.07 on October 30, 2026, down 1.30% on the day. The stock trades 19.7% below its 52-week high of $27.50 and 38.3% above its 52-week low of $15.96. Over the past year, it lost 15.5%. Zai Lab Limited is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price: $22.07
Day change: -1.30%
Volume: 637,837
Average volume: 1,038,184
Market cap: 2B+
52-week range: $15.96 – $27.50
50-day average: $25.02
200-day average: $20.97

Price action over the past year

In 252 trading sessions since October 30, 2025, ZLAB closed higher on 112 days (44%). Its best day was August 6, 2026 (+13.66%) and its worst was October 22, 2026 (-8.93%). The stock moved 10% or more in a single session 3 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

Oct 30, 2026: Trading sideways between $22.04 and $25.08 over 14 days (Sideways scanner)
Oct 23, 2026: News catalyst: Biotech (News Catalysts scanner)

ZLAB news

Oct 28, 2026: Zai Lab's Rally Meets A Test: Can Sequential Sales Gains Hold As Cash Burn Persists?
Oct 27, 2026: Asian Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
Oct 23, 2026: Asian Equities Traded in the US as American Depositary Receipts Decline in Friday Trading
Oct 23, 2026: Zai Lab's Zoci Shows 82% Response Rate in Early Lung Cancer Study
Oct 23, 2026: Zai Lab's Zocilurtatug Pelitecan (Zoci, Formerly ZL-1310) Demonstrates High Response Rates, Encouraging Durability and Well-Tolerated Safety Profile in First-Line Extensive-Stage Small Cell Lung Cancer
Oct 23, 2026: Zai Lab Says Zoci Plus Atezolizumab Improves Response Rate in Phase 1 Lung Cancer Trial
Oct 23, 2026: Zai Lab Announces $250 Million Private Placement
Oct 22, 2026: What argenex (ARGX) Said on Its Q3 Earnings Call

About Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company. The company is engaged in discovering or licensing, developing and commercializing proprietary therapeutics in the fields of oncology, autoimmune and infectious diseases.

Similar stocks

Find more stocks like ZLAB with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.